GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
last added cars
2023-07-17| R&D

Newly Discovered Anticoagulants Offer Hope for Sepsis and Covid Patients

by GeneOnline
Share To

Researchers at Trinity College Dublin discovered new anticoagulants that could help treat COVID and sepsis. The findings published in Nature Communications demonstrate that dimethyl sulfate can stop coagulation during infections, offering hope for its use in the treatment of blood clotting disorders like Disseminated intravascular coagulopathy (DIC). 

Related Article: Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals 

Use of Dimethyl Sulfate as an Anticoagulant  

The group of scientists uncovered that dimethyl sulfate (DMF), a drug used for the treatment of multiple sclerosis, and the related drug 4-octyl itaconate (4-OI) are able to decrease the blood’s ability to clot. The team was able to identify both DMF and 4-OI as inhibitors of inflammation-associated coagulation. They found that these drugs act by suppressing IFN-TF, a critical mediator of coagulation, in macrophages. Dr. Trsitam Ryan from the Trinity Biomedical Sciences Institute said, “DIC is one of the leading causes of death worldwide so we hope our findings might lead to new therapies that save lives.” 

Disseminated intravascular coagulopathy is a life-threatening condition that can develop in patients with bacterial or viral infections like COVID-19. DIC creates small blood clots, which affect circulation to major organs like the heart. This can then result in uncontrollable bleeding. Current treatment for DIC consists of transfusions of plasma and red blood cells and the use of anticoagulation medication. 

The researchers hope their findings will bring about new therapies for treating clotting disorders like DIC. These disorders are the leading cause of death in patients in intensive care units. The need for innovation in anticoagulation drugs is highlighted by the problems faced with current anticoagulation therapies. The existing therapies have an increased bleeding risk for patients, which is significantly enhanced in septic patients. The discovery of the use of dimethyl sulfate as an anticoagulant is opening new avenues in the treatment of these disorders.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
R&D
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
Scroll to Top